$3.92 +0.13 (%) Ampio Pharmaceuticals Inc - AMEX

Oct. 24, 2014 | 04:00 PM

Partner Headlines

  1. Ampio Offers Update on Phase III Multicenter, Double-Blind STEP Study of Ampion

    Benzinga | Sep. 2, 2014 | 07:57AM EST
  2. Ampio Pharma Announces Responses to Questions Related to STEP Study

    Benzinga | Aug. 25, 2014 | 08:03AM EST
  3. Morning Market Losers

    Benzinga | Aug. 22, 2014 | 09:58AM EST
  4. Benzinga's Top Downgrades

    Benzinga | Aug. 22, 2014 | 09:44AM EST
  5. Jefferies Downgrades Ampio Pharmaceuticals To Hold

    Benzinga | Aug. 22, 2014 | 08:33AM EST
  6. Morning Market Losers

    Benzinga | Aug. 21, 2014 | 10:02AM EST
  7. Ampio Pharmaceuticals' Vyrix Enters into an Agreement with Paladin Labs for Exclusive Rights to Zertane in Canada

    Benzinga | Apr. 10, 2014 | 08:05AM EST
  8. Ampio Pharma to Present Results of 20 Weeks Extension of Ampion SPRING Study at Western Orthopedic Association

    Benzinga | Apr. 9, 2014 | 08:11AM EST
  9. Ampio Pharmaceuticals Spins-Off Sexual Dysfunction Business

    Benzinga | Dec. 13, 2013 | 13:01PM EST
  10. Ampio Pharma Announces Results from Panel Review of the Interim Analysis of the Optina(TM) Trial, FDA Agrees to 505(B) 2 Pathway

    Benzinga | Oct. 7, 2013 | 08:06AM EST
  11. Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial

    Benzinga | Sep. 30, 2013 | 08:08AM EST
  12. Morning Market Movers

    Benzinga | Aug. 14, 2013 | 10:01AM EST
  13. Ampio Pharmaceuticals Announces Ampion Study Meets Primary Endpoint with High Statistical Significance; All Primary Study Objectives were Achieved

    Benzinga | Aug. 14, 2013 | 08:05AM EST
  14. FDA Accepts Ampio Pharmaceuticals IND for Optina for Treatment of Diabetic Macular Edema

    Benzinga | Jan. 21, 2013 | 22:50PM EST
  15. Health Care Sector Wrap

    FoxBusiness | Aug. 28, 2012 | 10:43AM EST
  16. Coinstar, Supervalu Among Stocks Down on Above-average Volume Friday

    FoxBusiness | Jul. 13, 2012 | 06:31AM EST
  17. Lexmark International, Ampio Pharmaceuticals Gapping Down Friday

    FoxBusiness | Jul. 13, 2012 | 04:31AM EST
  18. From Earlier: Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,6M Shares at $3.25

    Benzinga | Jul. 13, 2012 | 01:43AM EST
  19. Health Care Sector Wrap

    FoxBusiness | Jul. 12, 2012 | 10:50AM EST
  20. Amylin Pharmaceuticals, Best Buy Among Stocks Up on High Volume Monday

    FoxBusiness | Jul. 2, 2012 | 06:32AM EST
  21. Ampio Pharmaceuticals, Corinthian Colleges Among Stocks Gapping Up Monday

    FoxBusiness | Jul. 2, 2012 | 04:32AM EST
  22. Morning Market Movers

    Benzinga | Jul. 2, 2012 | 03:46AM EST
  23. Ampio Contracts with Syngene to Manufacture Zertane-ED, its Recently Patented Combination Drug

    Benzinga | Jul. 2, 2012 | 00:45AM EST
  24. From Earlier: Ampio Reports Successful Type B Pre-IND Meeting with the FDA for its Drug Zertane™ to treat Premature Ejaculation (PE)

    Benzinga | Jun. 21, 2012 | 01:50AM EST
  25. These 5 Small Cap Stocks Are Up Better Than 10% Today

    Benzinga | Jun. 11, 2012 | 07:44AM EST
  26. Ampio Shares Soar on Optina Results

    FoxBusiness | Jun. 11, 2012 | 07:13AM EST
  27. From Earlier: Ampio Announces Positive Clinical Trial Results for the Treatment of Diabetic Macular Edema with Orally Administered Optina™

    Benzinga | Jun. 11, 2012 | 02:12AM EST
  28. Ampio Pharmaceuticals Reports Pre-IND Meeting With the FDA to Obtain Clinical Path Guidance for Ampion

    Benzinga | May. 11, 2012 | 05:29AM EST
  29. Ampio Pharmaceuticals Reports Pre-IND Meeting With the FDA to Obtain Clinical Path Guidance for Ampion

    Benzinga | May. 11, 2012 | 01:01AM EST
  30. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion

    Benzinga | Dec. 22, 2011 | 04:50AM EST
  31. Ampio Responds to What May Be a Coordinated Short Selling Attack Against the Firm's Stock

    Benzinga | Dec. 16, 2011 | 01:37AM EST
Trading Center